Asia Pacific Animal Health Market by product (Parasiticides (Ectoparasiticides), Antimicrobial & Antibiotic, Vaccines, Feed Additive( Vitamin, Amino Acids, Antioxidant), Growth Promoter) Animal (Livestock, Companion), End-user (Hospitals) & Region - Global Forecast to 2025
The global Asia Pacific Animal Health Market in terms of revenue was estimated to be worth $15.6 billion in 2020 and is poised to reach $22.1 billion by 2025, growing at a CAGR of 7.2% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
Factors such as the rapid rise in livestock population, increasing awareness about animal health, and rising frequency of animal disease outbreaks are expected to drive the growth of the APAC animal health market. However, restrictions on the use of parasiticides in food-producing animals, shift toward vegetarian diets, and the rising cost of storage of animal vaccines are expected to restrain the growth of this market.
To know about the assumptions considered for the study, Request for Free Sample Report
APAC animal health Market Dynamics
Drivers: Rising demand of animal-derived food products
According to FAO, South Asia is one of the major regions for dairy production and accounted for 20–25% of the global milk production in 2019. In this region, India was the largest producer and consumer of milk, followed by China and Pakistan. In 2020, the consumption of meat in India was found to be over 3.9 million metric tons; by 2030, this is expected to increase to 145.7 million metric tons.
China accounted for the largest share of total pork, beef, and poultry meat consumption in the Asia Pacific region in 2019. The overall consumption of animal-derived food products is projected to increase by 2030.
Restraints: Shift towards vegetarian diet
There is a significant rise in the prevalence of obesity and other chronic disorders. Therefore, several people are shifting toward a vegetarian diet from a predominantly non-vegetarian diet. The prevalence of obesity has increased more than twofold since 1980. According to a journal published by Development Asia in 2018, two of five adults in the Asia Pacific region are found to be overweight or obese, and it is considered to be home to the largest absolute number of obese people, about 1 billion.
The prevalence of obesity in Asia Pacific ranges from less than 5% in India to 60% in Australia. Although the prevalence in China is a third of that in Australia, the increase in prevalence in China over the last 20 years was 400% compared to 20% in Australia.
Opportunities: Lucrative growth opportunities in India an China
Over the last few years, companion animal ownership has experienced steady growth, especially in emerging markets such as China and India. Rapid urbanization and growing disposable incomes are some of the key factors driving pet ownership in these countries. Many pet owners in these countries are now willing to spend more on pet care, specifically healthcare services.
These countries have robust livestock markets. According to a Dairy Tech India article, India is emerging as the world's second-largest poultry market, with an annual growth of more than 14%. India is the world's largest milk producer. According to the US Meat Export Federation, China ranks first in the world for pork consumption. The consumption of pork increased from 28.3 kg per person in 2012 to 34.2 kg per person in 2019.
Challenges: Growing resistance to parasites and antibodies
The prolonged use of specific parasiticides and antibiotics generates parasite resistance, which is a burning issue in the animal health market. Several farmers and pet owners tend to decrease the dosage of parasiticides or change the parasiticides used to combat resistance. However, this may prove detrimental in the long run and result in the development of multi-drug resistant parasite species.
The vaccines will have the highest growth rate, by product type, during the forecast period
Based on product, the APAC animal health market is segmented into parasiticides, antimicrobials and antibiotics, vaccines, feed additives/nutritional products, growth promoters, and other pharmaceuticals. Vaccines is expected to have the highest growth rate during the forecast period due to growing prevalence of animal-related diseases in Asian countries.
The food-producing animals had the largest share, by animal, in 2019.
Based on animal, the APAC animal health market is categorized into food-producing animals and companion animals. In 2019, food-producing animals accounted for large share of the APAC animal health market. The larger share of this segment is due to the increasing livestock population and rising demand for animal-derived food products.
Animal Farms are the largest end-user segment of the APAC animal health market.
Based on end-user, the market has been classified into veterinary hospitals & clinics, animal farms, and homecare. In 2019, the animal farms segment accounted for the largest market share of the APAC animal health market. This is because of the large population of livestock in emerging Asia Pacific countries, growing demand for animal-derived food products, and rising incidences of zoonotic diseases.
China market to witness the highest growth during the forecast period
The APAC animal health market is divided into five countries—China, Japan, India, Australia, and RoAPAC These are analyzed further at the country levels. The Asia Pacific market is driven primarily by the increasing disposable income, growing awareness about animal health, rising demand of animal derived food products, and growing adoption of companion animals.
To know about the assumptions considered for the study, download the pdf brochure
Key Market Players
The market is dominated by a few globally established players such as Zoetis (US), Boehringer Ingelheim (Germany), Elanco (US), Merck & Co. (US), and Dechra (UK).
|
Report Metric |
Details |
|
Market size available for years |
2018-2025 |
|
Base year considered |
2019 |
|
Forecast period |
2020–2025 |
|
Forecast units |
Value (USD Billion) |
|
Segments covered |
By Products, By Animal, By End-user |
|
Geographies covered |
Asia Pacific |
|
Companies covered |
The major market players include Boehringer Ingelheim (Germany), Zoetis Inc. (US), Elanco Animal Health (US), Merck & Co. Inc (US), Phibro Animal Health (US), Virbac (France), Vetoquinol S.A (France), Ceva Sante Animale (France), Dechra Pharmaceuticals Plc. (UK), Kyoritsu Seiyako (Japan), Tianjin Ringpu (China), China Animal Husbandry (China), and Jinyu Bio-Technology (China). |
The study categorizes the contact lenses market based on product, animal and end-user at the country levels.
By Products Type
-
By Parasiticides
-
Ectoparasiticides
- Pour ons & Spot ons
- Sprays
- Dips
- Ear-Tags
- Collars
- Oral Tablets
- Other Ectoparasiticides
-
Endoparasiticides
- Oral Liquids
- Oral Solids
- Injectables
- Feed Additives
- Other Endoparasiticides
- Endectocides
-
Ectoparasiticides
-
Antimicrobials & Antibiotics
- Tetracyclines
- Penicillins
- Sulfonamides
- Macrolides
- Others
-
Vaccines
- Live Attenuated Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
- Other Vaccines
-
Feed Additives/Nutritional Products
- Amino Acids
- Binders
- Vitamins
- Minerals
- Feed Acidifiers
- Antioxidants
- Other Feed Additives
-
Growth Promoter
- Acidifiers
- Hormonal Growth promoters
- Prebiotics & Probiotics
- Feed Enzymes
- Phytogenics
- Other Growth Promoters
- Other Pharmaceuticals
By Animal Type
-
Food Producing Animals
- Cattle
- Pigs
- Poultry
- Sheep & Goats
- Other Food Producing Animals
-
Companion Animals
- Cats
- Dogs
- Horses
- Other Companion Animals
By End-User
- Veterinary Hospitals & Clinics
- Animal Farms
- Homecare
Recent Developments
- In July 2020, Boehringer Ingelheim launched an external innovation hub in China.
- In July 2020, Merck acquired the US rights from Virbac for the SENTINEL brand of combination parasiticides used to protect dogs against fleas and common intestinal parasites.
- In July 2020, Zoetis announced a collaboration with Trianni for the development of transgenic monoclonal antibody platforms for the discovery of new veterinary treatments
- In April 2020, Elanco collaborated with VetNow to provide relief to veterinarians by expanding its products and service access through the telemedicine platform.
- In July 2017, Zoetis completed the acquisition of Nexvet, a biologic therapeutics company.
Frequently Asked Questions (FAQ):
Which type of animal health product is leading the by product type segment?
Based on product, the APAC animal health market is segmented into parasiticides, antimicrobials and antibiotics, vaccines, feed additives/nutritional products, growth promoters, and other pharmaceuticals. In 2019, feed additives accounted for the largest share of the APAC animal health market.
Which type of animal is leading the by animal segment?
Based on animal, the APAC animal health market is categorized into food-producing animals and companion animals. In 2019, food-producing animals accounted for largest share of the APAC animal health market.
Which is the leading end-user segment of APAC animal health market?
Based on end-user, the market has been classified into veterinary hospitals & clinics, animal farms, and homecare. In 2019, the animal farms segment accounted for the largest market share of the APAC animal health market.
Who are the key players operating in the APAC animal health market?
The APAC animal health market is highly competitive and fragmented. The prominent players operating in this market include Boehringer Ingelheim (Germany), Zoetis Inc. (US), Elanco Animal Health (US), Merck & Co. Inc (US), Phibro Animal Health (US), Virbac (France), Vetoquinol S.A (France), Hipra (Spain), Ceva Sante Animale (France), Dechra Pharmaceuticals Plc. (UK), Kyoritsu Seiyako (Japan), Tianjin Ringpu (China), China Animal Husbandry (China), Endovac Animal Health (US), Zydus (India), Indian Immunologicals Pvt Ltd. (India), UCBVET (US), Torigen Pharmaceuticals Inc. (US), Brilliant Bio Pharma Private Limited (India), Aptimmune Biologics (US), Ayurvet (India), Ashish Life Science (India), Alltech (US), Avitech (India), and Jinyu Bio-Technology (China).
Which country is dominating in the APAC animal health market?
The APAC animal health market is segmented into Japan, China, India, Australia and RoAPAC. In 2019, China dominated the APAC animal health market, followed by Japan and India. However, India is estimated to register the highest CAGR during the forecast period. The growth of this market can be attributed to the large animal population, increasing prevalence of zoonotic diseases, rising adoption of companion animals and increasing awareness about animal health. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 27)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION & SCOPE
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKETS COVERED
FIGURE 1 APAC ANIMAL HEALTH MARKET
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 LIMITATIONS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 32)
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION
FIGURE 7 COUNTRY-LEVEL ANALYSIS OF THE APAC ANIMAL HEALTH MARKET
FIGURE 8 APPROACH 4: TOP-DOWN APPROACH
FIGURE 9 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE APAC ANIMAL HEALTH MARKET (2020-2025)
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 11 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ASSUMPTIONS
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY (Page No. - 44)
FIGURE 12 APAC ANIMAL HEALTH MARKET, BY PRODUCT TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 13 APAC ANIMAL HEALTH MARKET, BY ANIMAL, 2020 VS. 2025 (USD MILLION)
FIGURE 14 APAC ANIMAL HEALTH MARKET, BY END-USER, 2020 VS. 2025 (USD MILLION)
4 PREMIUM INSIGHTS (Page No. - 46)
4.1 APAC ANIMAL HEALTH MARKET OVERVIEW
FIGURE 15 EMERGING COUNTRIES TO OFFER GROWTH OPPORTUNITIES FOR MARKET PLAYERS
4.2 ASIA PACIFIC: ANIMAL HEALTH MARKET, BY PRODUCT TYPE AND END-USER (2019)
FIGURE 16 ANIMAL FARMS SEGMENT & FEED ADDITIVES ACCOUNTED FOR THE LARGEST MARKET SHARES IN 2019
5 MARKET OVERVIEW (Page No. - 48)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 APAC ANIMAL HEALTH MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising demand for animal-derived food products
FIGURE 18 COUNTRY-LEVEL CONSUMPTION OF ANIMAL DERIVED FOOD PRODUCTS (2020-2030), THOUSAND METRIC TONS
FIGURE 19 COUNTRY-LEVEL PRODUCTION OF ANIMAL DERIVED FOOD PRODUCTS (2020-2030), THOUSAND METRIC TONS
FIGURE 20 ASIA WAS THE HIGHEST CONSUMER OF MEAT AND MILK IN THE WORLD IN 2018
5.2.1.2 Increasing livestock population and growing awareness about animal health
TABLE 1 APAC LIVESTOCK POPULATION, IN MILLION, 2014-2018
FIGURE 21 CATTLE POPULATION IN ASIA PACIFIC COUNTRIES, 2018 (IN MILLION)
5.2.1.3 Growing frequency of animal disease outbreaks
TABLE 2 ANIMAL DISEASE OUTBREAK IN ASIA PACIFIC COUNTRIES (2009-2019)
5.2.2 RESTRAINTS
5.2.2.1 Restrictions on use of parasiticides in food-producing animals
5.2.2.2 Shift toward vegetarian diet
5.2.2.3 Rising vaccine storage cost
5.2.3 OPPORTUNITIES
5.2.3.1 Lucrative growth opportunities in India and China
5.2.3.2 Growth in companion animal ownership and rising adoption of pet health insurance
5.2.4 CHALLENGES
5.2.4.1 Growing resistance to parasiticides and antibiotics
TABLE 3 PARASITICIDES AND RESISTANT PARASITES
5.2.4.2 Diversity of parasite species
5.2.4.3 Inadequate surveillance and reporting systems of vaccines
5.2.4.4 High costs of feed additive leading to adoption of conventional feeding systems
5.2.5 INDUSTRY TRENDS
5.2.5.1 Innovations in animal healthcare products
TABLE 4 INNOVATIVE ANIMAL PHARMACEUTICAL TRENDS
5.2.5.2 Consolidation in animal health industry
TABLE 5 SOME MAJOR ACQUISITIONS IN ANIMAL HEALTH INDUSTRY (2017-2019)
5.3 COVID-19 HEALTH ASSESSMENT
5.4 COVID-19 ECONOMIC ASSESSMENT
5.5 ASSESSMENT OF COVID-19 IMPACT ON ECONOMIC SCENARIO
FIGURE 22 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 23 SCENARIOS OF THE RECOVERY OF THE GLOBAL ECONOMY
5.6 ASSESSMENT OF IMPACT OF COVID-19 ON ECONOMIC SCENARIO PERTAINING TO APAC ANIMAL HEALTH MARKET
5.7 VALUE CHAIN ANALYSIS
FIGURE 24 APAC ANIMAL HEALTH MARKET: VALUE CHAIN ANALYSIS
5.8 ECOSYSTEM MARKET MAP
FIGURE 25 APAC ANIMAL HEALTH MARKET: ECOSYSTEM MARKET MAP
6 APAC ANIMAL HEALTH MARKET, BY PRODUCT (Page No. - 66)
6.1 INTRODUCTION
TABLE 6 APAC ANIMAL HEALTH MARKET, BY PRODUCT TYPE 2018–2025 (USD MILLION)
6.2 GROWTH PROMOTERS
TABLE 7 APAC ANIMAL GROWTH PROMOTERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 8 APAC ANIMAL GROWTH PROMOTERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.1 PROBIOTICS & PREBIOTICS
6.2.1.1 Restrictions on the use of antibiotics have promoted the growth of probiotics & prebiotics
TABLE 9 APAC PROBIOTICS & PREBIOTICS GROWTH PROMOTERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.2 ACIDIFIERS
6.2.2.1 Regulations on the use of antibiotics and wide applications in different food-producing animals are driving the use of acidifiers
TABLE 10 APAC ACIDIFIERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.3 PHYTOGENICS
6.2.3.1 Natural performance enhancement and antioxidative and disease defense properties support the use of phytogenics
TABLE 11 APAC PHYTOGENICS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.4 FEED ENZYME GROWTH PROMOTERS
6.2.4.1 Feed enzymes segment is expected to benefit significantly due to the ban on antibiotics and hormones
TABLE 12 APAC FEED ENZYME GROWTH PROMOTERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.5 HORMONAL GROWTH PROMOTERS
6.2.5.1 Routine use of hormonal growth promoters in east Asian countries contribute to their market growth
TABLE 13 APAC HORMONAL GROWTH PROMOTERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.6 OTHER GROWTH PROMOTERS
TABLE 14 APAC OTHER GROWTH PROMOTERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.3 FEED ADDITIVES/NUTRITIONAL PRODUCTS
TABLE 15 APAC ANIMAL FEED ADDITIVES/NUTRITIONAL PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 16 APAC ANIMAL FEED ADDITIVES/NUTRITIONAL PRODUCTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.3.1 AMINO ACIDS
6.3.1.1 High nutritional benefits and low cost drive the growth of amino acids
TABLE 17 APAC AMINO ACIDS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.3.2 BINDERS
6.3.2.1 Binders increase productivity of animal derived products, leading to their market growth
TABLE 18 APAC BINDERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.3.3 VITAMINS
6.3.3.1 Rising importance of vitamins as a key constituent for metabolic functions in livestock is projected to drive the market
TABLE 19 APAC VITAMINS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.3.4 MINERALS
6.3.4.1 Multiple functions of minerals in animals driving growth
TABLE 20 APAC MINERALS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.3.5 FEED ACIDIFIERS
6.3.5.1 Improvement in economic performance of livestock due to feed acidifiers expected to lead to market growth
TABLE 21 APAC FEED ACIDIFIERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.3.6 ANTIOXIDANTS
6.3.6.1 Reduced wastage and improved nutrition promote the growth of antioxidants
TABLE 22 APAC ANTIOXIDANTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.3.7 OTHER FEED ADDITIVES/NUTRITIONAL PRODUCTS
TABLE 23 APAC OTHER FEED ADDITIVES/NUTRITIONAL PRODUCTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.4 VACCINES
TABLE 24 APAC ANIMAL VACCINE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 25 APAC ANIMAL VACCINE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.4.1 LIVE ATTENUATED VACCINE
6.4.1.1 Live attenuated vaccine accounted for the largest share of the APAC animal vaccine market in 2019
TABLE 26 APAC LIVE ATTENUATED VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.4.2 INACTIVATED VACCINES
6.4.2.1 High cost and short-lasting immunity hinder the growth of inactivated vaccines
TABLE 27 APAC INACTIVATED VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.4.3 TOXOID VACCINES
6.4.3.1 Safety and stability of toxoid vaccines to lead to market growth
TABLE 28 APAC TOXOID VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.4.4 RECOMBINANT VACCINES
6.4.4.1 Advantages associated with recombinant vaccines driving their demand
TABLE 29 APAC RECOMBINANT VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.4.5 OTHER VACCINES
TABLE 30 APAC OTHER VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.5 PARASITICIDES
TABLE 31 APAC ANIMAL PARASITICIDES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 32 APAC ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.5.1 ECTOPARASITICIDES
TABLE 33 APAC ANIMAL ECTOPARASITICIDES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 34 APAC ANIMAL ECTOPARASITICIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.5.1.1 Pour-ons & spot-ons
6.5.1.1.1 Ease of application support the demand for pour-ons & spot-ons
TABLE 35 APAC ANIMAL ECTOPARASITICIDE POUR-ONS & SPOT-ONS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.5.1.2 Oral tablets
6.5.1.2.1 High medication compliance and ease of administration are key growth drivers in this market
TABLE 36 APAC ANIMAL ORAL ECTOPARASITICIDE TABLETS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.5.1.3 Sprays
6.5.1.3.1 Low price and convenient handling drive market growth
TABLE 37 APAC ANIMAL ECTOPARASITICIDE SPRAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.5.1.4 Dips
6.5.1.4.1 The high popularity of dips ensures sustained end user demand
TABLE 38 APAC ANIMAL ECTOPARASITICIDE DIPS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.5.1.5 Ear tags
6.5.1.5.1 Ear tags are highly effective in controlling flies around cattle
TABLE 39 APAC ANIMAL ECTOPARASITICIDE EAR TAGS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.5.1.6 Collars
6.5.1.6.1 Increasing prevalence of infections in companion animals drive the growth of collars
TABLE 40 APAC ANIMAL ECTOPARASITICIDE COLLARS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.5.1.7 Other ectoparasiticides
TABLE 41 APAC ANIMAL OTHER ECTOPARASITICIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.5.2 ENDOPARASITICIDES
TABLE 42 APAC ANIMAL ENDOPARASITICIDES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 43 APAC ANIMAL ENDOPARASITICIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.5.2.1 Oral liquids
6.5.2.1.1 Increasing demand for meat and milk drives the growth of the oral liquids market
TABLE 44 APAC ANIMAL ORAL LIQUID ENDOPARASITICIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.5.2.2 Oral solids
6.5.2.2.1 The emergence of internal parasitic infections in dogs is expected to drive the growth of the oral solids market
TABLE 45 APAC ANIMAL ORAL SOLID ENDOPARASITICIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.5.2.3 Injectables
6.5.2.3.1 Injectables offer rapid results, which has supported their use
TABLE 46 APAC ANIMAL INJECTABLE ENDOPARASITICIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.5.2.4 Feed additives
6.5.2.4.1 Feed additives can be administered to large numbers of animals at once
TABLE 47 APAC ANIMAL FEED ADDITIVES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.5.2.5 Other endoparasiticides
TABLE 48 APAC ANIMAL OTHER ENDOPARASITICIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.5.3 ENDECTOCIDES
6.5.3.1 Multiple applications against several parasites drive the growth of endectocides
TABLE 49 PLAYERS IN THE ENDECTOCIDES MARKET
TABLE 50 APAC ANIMAL ENDECTOCIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.6 ANTIMICROBIALS & ANTIBIOTICS
TABLE 51 APAC ANIMAL ANTIMICROBIALS & ANTIBIOTICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 52 APAC ANIMAL ANTIMICROBIALS & ANTIBIOTICS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.6.1 TETRACYCLINES
6.6.1.1 Reduced cost is a key factor driving higher use of tetracyclines across emerging Asian countries
TABLE 53 APAC TETRACYCLINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.6.2 PENICILLINS
6.6.2.1 Rising incidences of zoonotic diseases in livestock animals expected to drive growth of penicillins
TABLE 54 APAC PENICILLINS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.6.3 SULFONAMIDES
6.6.3.1 Reduced cost and multiple applications in livestock infections drive demand for sulfonamides in rural Asian regions
TABLE 55 APAC SULFONAMIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.6.4 MACROLIDES
6.6.4.1 Increasing production of cattle derived food products expected to drive the growth of macrolides
TABLE 56 APAC MACROLIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.6.5 AMINOGLYCOSIDES
6.6.5.1 Rising prevalence of animal-related diseases in rural regions of Asia Pacific expected to drive the demand for aminoglycosides
TABLE 57 APAC AMINOGLYCOSIDES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.6.6 CEPHALOSPORINS
6.6.6.1 Increasing adoption of pets in Asian countries expected to drive the growth of cephalosporins
TABLE 58 APAC CEPHALOSPORINS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.6.7 OTHER ANTIBIOTICS & ANTIMICROBIALS
TABLE 59 APAC OTHER ANTIBIOTICS & ANTIMICROBIALS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.7 OTHER PHARMACEUTICALS
TABLE 60 APAC OTHER PHARMACEUTICALS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7 APAC ANIMAL HEALTH MARKET, BY ANIMAL (Page No. - 105)
7.1 INTRODUCTION
TABLE 61 APAC ANIMAL HEALTH MARKET, BY ANIMAL, 2018–2025 (USD MILLION)
7.2 FOOD PRODUCING ANIMALS
TABLE 62 PER CAPITA CONSUMPTION OF MEAT IN MAJOR APAC COUNTRIES, (IN KG), 2019
TABLE 63 APAC ANIMAL HEALTH MARKET FOR FOOD PRODUCING ANIMALS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 64 FOOD-PRODUCING ANIMAL, BY COUNTRY, 2018–2025 (USD MILLION)
7.2.1 CATTLE
7.2.1.1 Increasing beef consumption and milk production to drive the segment
TABLE 65 APAC ANIMAL HEALTH MARKET FOR CATTLE, BY COUNTRY, 2018–2025 (USD MILLION)
7.2.2 PIGS
7.2.2.1 Growing incidences of zoonotic diseases will require better health maintenance of pigs
TABLE 66 APAC ANIMAL HEALTH MARKET FOR PIGS, BY COUNTRY, 2018–2025 (USD MILLION)
7.2.3 POULTRY
7.2.3.1 Growing egg consumption in emerging countries to drive the segment
FIGURE 26 LEADING EGG PRODUCING COUNTRIES IN ASIA PACIFIC (NUMBER OF EGGS, IN BILLION), 2018
TABLE 67 APAC ANIMAL HEALTH MARKET FOR POULTRY, BY COUNTRY, 2018–2025 (USD MILLION)
7.2.4 SHEEP AND GOATS
7.2.4.1 Increasing population of sheep and goats is expected to drive the segment
TABLE 68 APAC ANIMAL HEALTH MARKET FOR SHEEP AND GOATS, BY COUNTRY, 2018–2025 (USD MILLION)
7.2.5 OTHER FOOD-PRODUCING ANIMALS
FIGURE 27 CONSUMPTION OF FISH AND FISH PRODUCTS PER YEAR IN ASIAN COUNTRIES, PER CAPITA (IN KG)
TABLE 69 APAC ANIMAL HEALTH MARKET FOR OTHER FOOD PRODUCING ANIMALS, BY COUNTRY, 2018–2025 (USD MILLION)
7.3 COMPANION ANIMALS
TABLE 70 APAC COMPANION ANIMAL MARKET, BY TYPE 2018–2025 (USD MILLION)
TABLE 71 APAC COMPANION ANIMAL MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7.3.1 DOGS
7.3.1.1 Growing adoption of dogs to drive the segment
FIGURE 28 GROWING POPULATION OF PET DOGS IN INDIA (MILLION)
TABLE 72 APAC ANIMAL HEALTH MARKET FOR DOGS, BY COUNTRY, 2018–2025 (USD MILLION)
7.3.2 CATS
7.3.2.1 Increasing adoption of cats in South Asia to drive the segment
TABLE 73 APAC ANIMAL HEALTH MARKET FOR CATS, BY COUNTRY, 2018–2025 (USD MILLION)
7.3.3 HORSES
7.3.3.1 Declining horse population demands adoption of health products
TABLE 74 APAC ANIMAL HEALTH MARKET FOR HORSES, BY COUNTRY, 2018–2025 (USD MILLION)
7.3.4 OTHER COMPANION ANIMALS
TABLE 75 APAC ANIMAL HEALTH MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2018–2025 (USD MILLION)
8 APAC ANIMAL HEALTH MARKET, BY END-USER (Page No. - 118)
8.1 INTRODUCTION
TABLE 76 APAC ANIMAL HEALTH MARKET, BY END-USER, 2018–2025 (USD MILLION)
8.2 ANIMAL FARMS
8.2.1 GROWING LIVESTOCK POPULATION IN DEVELOPING COUNTRIES TO DRIVE THE SEGMENT
TABLE 77 GROWTH IN PRODUCTION OF MEAT AND MILK IN ASIA, 2015–2030, BY REGION
TABLE 78 GROWTH IN CONSUMPTION OF MEAT AND MILK IN ASIA, 2015–2030, BY REGION
TABLE 79 GROWTH IN PRODUCTION OF LIVESTOCK COMMODITIES IN ASIA, THOUSAND TONNES,2017–2030
TABLE 80 APAC ANIMAL HEALTH MARKET FOR ANIMAL FARMS, BY COUNTRY, 2018–2025 (USD MILLION)
8.3 VETERINARY HOSPITALS & CLINICS
8.3.1 GROWING ANIMAL HEALTH AWARENESS WILL DRIVE THE SEGMENT
FIGURE 29 ASIA PACIFIC TO SHOW HIGHEST GROWTH RATE IN PET INDUSTRY BY 2022
TABLE 81 APAC ANIMAL HEALTH MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2018–2025 (USD MILLION)
8.4 HOMECARE
8.4.1 RISING PET OWNERSHIP RATES TO DRIVE THE SEGMENT
TABLE 82 APAC ANIMAL HEALTH MARKET FOR HOMECARE, BY COUNTRY, 2018–2025 (USD MILLION)
9 APAC ANIMAL HEALTH MARKET, BY COUNTRY (Page No. - 124)
9.1 INTRODUCTION
FIGURE 30 APAC ANIMAL HEALTH MARKET: SNAPSHOT
9.1.1 CHINA
9.1.1.1 Increasing pork consumption and growing pet adoption to drive the market
FIGURE 31 CHINA: PROJECTED COMPANION ANIMAL POPULATION, 2018-2025 (MILLION)
FIGURE 32 CHINA: PROJECTED FOOD-PRODUCING ANIMAL POPULATION, 2018–2025 (MILLION)
FIGURE 33 INCREASING CONSUMPTION OF PORK PRODUCTS IN CHINA, PER CAPITA (IN KILOGRAMS) (2011–2020)
FIGURE 34 GROWING CATTLE PRODUCTION IN CHINA, PER THOUSAND HEAD, 2009–2020
TABLE 83 CHINA: ANIMAL FEED ADDITIVE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 84 CHINA: ANIMAL GROWTH PROMOTER PRODUCT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 85 CHINA: ANIMAL VACCINE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 86 CHINA: ANIMAL PARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 87 CHINA: ANIMAL ECTOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 88 CHINA: ANIMAL ENDOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 89 CHINA: ANIMAL ANTIBIOTIC & ANTIMICROBIAL MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 90 CHINA: APAC ANIMAL HEALTH MARKET, BY ANIMAL, 2018–2025 (USD MILLION)
TABLE 91 CHINA: APAC ANIMAL HEALTH MARKET, BY COMPANION ANIMAL, 2018–2025 (USD MILLION)
TABLE 92 CHINA: APAC ANIMAL HEALTH MARKET, BY FOOD-PRODUCING ANIMAL, 2018–2025 (USD MILLION)
TABLE 93 CHINA: APAC ANIMAL HEALTH MARKET, BY END-USER, 2018–2025 (USD MILLION)
9.1.2 JAPAN
9.1.2.1 Rising awareness about zoonotic diseases is expected to drive the market
FIGURE 35 JAPAN: PROJECTED COMPANION ANIMAL POPULATION, 2018-2025 (MILLION)
FIGURE 36 JAPAN: PROJECTED FOOD-PRODUCING ANIMAL POPULATION, 2018–2025 (MILLION)
TABLE 94 PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS IN JAPAN (2000 VS. 2030) (THOUSAND METRIC TONS)
TABLE 95 JAPAN: ANIMAL FEED ADDITIVE/NUTRITIONAL PRODUCT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 96 JAPAN: ANIMAL GROWTH PROMOTER MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 97 JAPAN: ANIMAL VACCINE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 98 JAPAN: ANIMAL PARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 99 JAPAN: ANIMAL ECTOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 100 JAPAN: ANIMAL ENDOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 101 JAPAN: ANIMAL ANTIBIOTIC & ANTIMICROBIAL MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 102 JAPAN: APAC ANIMAL HEALTH MARKET, BY ANIMAL, 2018–2025 (USD MILLION)
TABLE 103 JAPAN: APAC ANIMAL HEALTH MARKET, BY COMPANION ANIMAL, 2018–2025 (USD MILLION)
TABLE 104 JAPAN: APAC ANIMAL HEALTH MARKET, BY FOOD-PRODUCING ANIMAL, 2018–2025 (USD MILLION)
TABLE 105 JAPAN: APAC ANIMAL HEALTH MARKET, BY END-USER, 2018–2025 (USD MILLION)
9.1.3 INDIA
9.1.3.1 Large livestock population and increasing production and export capacities to drive the market
FIGURE 37 INDIA: PROJECTED COMPANION ANIMAL POPULATION, 2018–2025 (MILLION)
FIGURE 38 INDIA: PROJECTED FOOD-PRODUCING ANIMAL POPULATION, 2018–2025, (MILLION)
FIGURE 39 INCREASING LIVESTOCK AND POULTRY POPULATION IN INDIA, 2003–2019 (MILLION)
TABLE 106 INDIA: ANIMAL FEED ADDITIVE/NUTRITIONAL PRODUCT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 107 INDIA: ANIMAL GROWTH PROMOTER MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 108 INDIA: ANIMAL VACCINE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 109 INDIA: ANIMAL PARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 110 INDIA: ANIMAL ECTOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 111 INDIA: ANIMAL ENDOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 112 INDIA: ANIMAL ANTIBIOTIC & ANTIMICROBIAL MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 113 INDIA: APAC ANIMAL HEALTH MARKET, BY ANIMAL, 2018–2025 (USD MILLION)
TABLE 114 INDIA: APAC ANIMAL HEALTH MARKET, BY COMPANION ANIMAL, 2018–2025 (USD MILLION)
TABLE 115 INDIA: APAC ANIMAL HEALTH MARKET, BY FOOD-PRODUCING ANIMAL, 2018–2025 (USD MILLION)
TABLE 116 INDIA: APAC ANIMAL HEALTH MARKET, BY END-USER, 2018–2025 (USD MILLION)
9.1.4 AUSTRALIA
9.1.4.1 Increasing pet population is expected to drive the market
FIGURE 40 AUSTRALIA: PROJECTED COMPANION ANIMAL POPULATION, 2018–2025 (MILLION)
FIGURE 41 AUSTRALIA: PROJECTED FOOD-PRODUCING ANIMAL POPULATION, 2018–2025 (MILLION)
TABLE 117 AUSTRALIA: ANIMAL FEED ADDITIVE/NUTRITIONAL PRODUCT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 118 AUSTRALIA: ANIMAL GROWTH PROMOTER MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 119 AUSTRALIA: ANIMAL VACCINE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 120 AUSTRALIA: ANIMAL PARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 121 AUSTRALIA: ANIMAL ECTOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 122 AUSTRALIA: ANIMAL ENDOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 123 AUSTRALIA: ANIMAL ANTIBIOTIC & ANTIMICROBIAL MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 124 AUSTRALIA: APAC ANIMAL HEALTH MARKET, BY ANIMAL, 2018-2025(USD MILLION)
TABLE 125 AUSTRALIA: APAC ANIMAL HEALTH MARKET, BY COMPANION ANIMAL, 2018-2025 (USD MILLION)
TABLE 126 AUSTRALIA: APAC ANIMAL HEALTH MARKET, BY FOOD-PRODUCING ANIMAL, 2018-2025(USD MILLION)
TABLE 127 AUSTRALIA: APAC ANIMAL HEALTH MARKET, BY END-USER, 2018–2025 (USD MILLION)
9.1.5 REST OF ASIA PACIFIC
TABLE 128 ROAPAC: ANIMAL FEED ADDITIVE/NUTRITIONAL PRODUCT MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 129 ROAPAC: ANIMAL GROWTH PROMOTER MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 130 ROAPAC: ANIMAL VACCINE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 131 ROAPAC: ANIMAL PARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 132 ROAPAC: ANIMAL ECTOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 133 ROAPAC: ANIMAL ENDOPARASITICIDE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 134 ROAPAC: ANIMAL ANTIBIOTIC & ANTIMICROBIAL MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 135 ROAPAC: APAC ANIMAL HEALTH MARKET, BY ANIMAL, 2018-2025(USD MILLION)
TABLE 136 ROAPAC: APAC ANIMAL HEALTH MARKET, BY COMPANION ANIMAL, 2018-2025(USD MILLION)
TABLE 137 ROAPAC: APAC ANIMAL HEALTH MARKET, BY FOOD-PRODUCING ANIMAL, 2018-2025(USD MILLION)
TABLE 138 ROAPAC: APAC ANIMAL HEALTH MARKET, BY END-USER, 2018–2025 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 156)
10.1 INTRODUCTION
FIGURE 42 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN 2017 AND 2020
10.2 MARKET EVALUATION FRAMEWORK
FIGURE 43 MARKET EVALUATION FRAMEWORK: MARKET CONSOLIDATION THROUGH PARTNERSHIPS, COLLABORATIONS, ACQUISITIONS, AND AGREEMENTS IN 2019
10.3 PRODUCT PORTFOLIO MATRIX
10.3.1 PARASITICIDES
10.3.2 VACCINES
10.3.3 ANTIBIOTICS & ANTIMICROBIALS
10.3.4 FEED ADDITIVES & NUTRITIONAL PRODUCTS
10.3.5 GROWTH PROMOTERS
10.4 APAC ANIMAL HEALTH MARKET: GEOGRAPHICAL ASSESSMENT
FIGURE 44 GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN THE APAC ANIMAL HEALTH MARKET (2019)
10.5 APAC ANIMAL HEALTH MARKET: R&D EXPENDITURE
FIGURE 45 R&D EXPENDITURE OF KEY PLAYERS IN THE ANIMAL HEALTH MARKET (2019)
10.6 REVENUE ANALYSIS OF KEY MARKET PLAYERS
FIGURE 46 REVENUE ANALYSIS: APAC ANIMAL HEALTH MARKET 2019
10.7 VENDOR DIVE
10.7.1 STARS
10.7.2 EMERGING LEADERS
10.7.3 PERVASIVE
10.7.4 EMERGING COMPANIES
FIGURE 47 COMPETITIVE LEADERSHIP MAPPING: APAC ANIMAL HEALTH MARKET, 2019
10.8 MARKET SHARE ANALYSIS
FIGURE 48 ANIMAL HEALTH MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
10.9 COMPETITIVE SITUATIONS AND TRENDS
FIGURE 49 BATTLE FOR MARKET SHARE: PRODUCT LAUNCHES & APPROVALS ACCOUNTED FOR THE LARGEST SHARE OF THE TOTAL DEVELOPMENTS PURSUED BY MARKET PLAYERS BETWEEN 2017 & 2020
10.9.1 PRODUCT LAUNCHES AND ENHANCEMENTS
TABLE 139 PRODUCT LAUNCHES AND ENHANCEMENTS (2017 – SEPTEMBER 2020)
10.9.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
TABLE 140 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017–SEPTEMBER 2020)
10.9.3 MERGERS & ACQUISITIONS AND DIVESTITURES
TABLE 141 MERGERS & ACQUISITIONS, DIVESTITURES (2017–SEPTEMBER 2020)
10.9.4 EXPANSIONS
TABLE 142 EXPANSIONS (2017–SEPTEMBER 2020)
11 STARTUP MATRIX (Page No. - 173)
11.1 COMPETITIVE LEADERSHIP MAPPING (SMES/STARTUP)
11.1.1 PROGRESSIVE COMPANIES
11.1.2 STARTING BLOCKS
11.1.3 RESPONSIVE COMPANIES
11.1.4 DYNAMIC COMPANIES
FIGURE 50 EMERGING PLAYERS VENDOR DIVE: EVALUATION OVERVIEW
12 COMPANY PROFILES (Page No. - 175)
(Business Overview, Products Offered, Recent Developments, MnM View, Strategic Overview, Right To Win)*
12.1 BOEHRINGER INGELHEIM
FIGURE 51 BOEHRINGER INGELHEIM: COMPANY SNAPSHOT (2019)
12.2 ELANCO ANIMAL HEALTH
FIGURE 52 ELANCO: COMPANY SNAPSHOT (2019)
12.3 MERCK ANIMAL HEALTH
FIGURE 53 MERCK: COMPANY SNAPSHOT (2019)
12.4 ZOETIS INC.
FIGURE 54 ZOETIS: COMPANY SNAPSHOT (2019)
12.5 VIRBAC
FIGURE 55 VIRBAC: COMPANY SNAPSHOT (2019)
12.6 VETOQUINOL S.A.
FIGURE 56 VETOQUINOL: COMPANY SNAPSHOT (2019)
12.7 PHIBRO ANIMAL HEALTH
FIGURE 57 PHIBRO ANIMAL HEALTH: COMPANY SNAPSHOT (2019)
12.8 CEVA SANTÉ ANIMALE
12.9 DECHRA PHARMACEUTICALS PLC.
FIGURE 58 DECHRA: COMPANY SNAPSHOT (2019)
12.10 KYORITSU SEIYAKO
12.11 TIANJIN RINGPU
12.12 CHINA ANIMAL HUSBANDRY
12.13 JINYU BIO-TECHNOLOGY
12.14 ZYDUS ANIMAL HEALTH
FIGURE 59 ZYDUS: COMPANY SNAPSHOT (2019)
12.15 HIPRA
12.16 ENDOVAC ANIMAL HEALTH
12.17 BOVICURE PHARMA
12.18 INDIAN IMMUNOLOGICALS LTD.
12.19 ASHISH LIFE SCIENCE (ALS)
12.20 LUTIM PHARMA
*Business Overview, Products Offered, Recent Developments, MnM View Strategic Overview, Right To Win might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 243)
13.1 INSIGHTS OF INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS
This study involved four major activities for estimating the current size of the APAC animal health market. Exhaustive secondary research was conducted to collect information on the market and its peer and parent markets. The next step focused on validating these findings, assumptions, and sizing with industry experts across the value chain through primary research. Revenue Share Analysis, Parent Market, and top-down approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the sizes of segments and sub-segments.
Secondary Research
In the secondary research process, various secondary sources such as D&B Hoovers, Bloomberg Business, and Factiva have been referred to identify and collect information for this study. These secondary sources include annual reports, press releases and investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard and silver-standard websites, regulatory bodies, and databases.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies operating in the APAC animal health market. Primary sources from the demand side include experts from hospitals and clinics and research and academic laboratories. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on the key industry trends and key market dynamics, such as market drivers, restraints, challenges, and opportunities.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total size of the APAC animal health market was arrived at after data triangulation from two different approaches, as mentioned below.
Approach to calculate the revenue of different players in the APAC animal health market
The size of the APAC animal health market was obtained from annual reports, SEC filings, online publications, and extensive primary interviews. A percentage split was applied to arrive at the size of market segments. Further splits were applied to arrive at the size for each sub-segment. These percentage splits were validated by primary participants. The country-level market sizes obtained from the annual reports, SEC filings, online publications, and extensive primary interviews were added up to reach the total market size for regions. By adding up the market sizes for all the regions, the global APAC animal health market was derived.
Approach to derive the market size and estimate market growth
The market size and market growth were estimated through primary interviews on a regional and global level. All responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.
Data Triangulation
After arriving at the overall market size—using the market size estimation processes explained above—the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Objectives of the Study
- To define, describe, and forecast the APAC animal health market based on product and animal type, and end user.
- To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets1 with respect to the individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To strategically profile the key players and comprehensively analyze their market shares and core competencies2 in the APAC animal health market
- To track and analyze competitive developments such as partnerships, agreements, collaborations, acquisitions, new product developments, geographic expansions, and research and development activities in the APAC animal health market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of the top companies
Geographic Analysis
- Further breakdown of the RoAPAC market into South Korea, New Zealand, Singapore, and other countries.
Company Information
- Detailed analysis and profiling of additional market players, up to five.
Generating Response ...
Growth opportunities and latent adjacency in Asia Pacific Animal Health Market